Beth is a seasoned leader with 18 years of experience in risk management, governance and regulatory compliance in the pharmaceutical industry. With her focus on AI governance, she recognizes the opportunities and risks of rapidly changing AI technology and the increasing AI adoption in the biotechnology and life science sectors. Beth advises organizations on developing frameworks for responsible AI use, mitigating AI-driven risks, and leveraging AI for business advantage. She is also a recognized speaker on AI governance, risk, and compliance.